Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subarachnoid bone marrow mesenchymal stem cell injection for spinal cord injury
IRCT2013050813267N1Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Dec 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bone marrow-derived mesenchymal stem cells in spinal cord injury (SCI), sponsored by Shahid Sadoughi University of Medical Sciences. Started Dec 2016; status: completed.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on IRCT2013050813267N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013050813267N1.